Here are five insights:
1. The offering was valued at 4.6 million common stock shares.
2. The offering included the full exercise for the underwriters to purchase 600,000 more shares at $13 per share.
3. On Oct. 12, these shares started trading on NASDAQ as “KIDS.”
4. Piper Jaffray and Stifel served as joint book-running managers, with William Blair acting as lead manager and BTIG as co-manager.
5. OrthoPediatrics develops products for the pediatric orthopedic market.
More articles on devices:
Arthrex to build $30M manufacturing plant in South Carolina: 5 insights
Johnson & Johnson medical device segment reports 4.9% sales growth in 2Q 2017 – to see greater growth in 3Q
Orthopaedic Implant Company launches external fixation system: 5 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
